TY - JOUR AU - Dent, R. AU - Hanna, W. M. AU - Trudeau, M. AU - Rawlinson, E. AU - Sun, P. AU - Narod, S. A. PY - 2009 DA - 2009// TI - Pattern of metastatic spread in triple-negative breast cancer JO - Breast Cancer Res Treat. VL - 115 UR - https://doi.org/10.1007/s10549-008-0086-2 DO - 10.1007/s10549-008-0086-2 ID - Dent2009 ER - TY - JOUR AU - Dent, R. AU - Trudeau, M. AU - Pritchard, K. I. AU - Hanna, W. M. AU - Kahn, H. K. AU - Sawka, C. A. PY - 2007 DA - 2007// TI - Triple-negative breast cancer: clinical features and patterns of recurrence JO - Clin Cancer Res. VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-3045 DO - 10.1158/1078-0432.CCR-06-3045 ID - Dent2007 ER - TY - JOUR AU - Haffty, B. G. AU - Yang, Q. AU - Reiss, M. AU - Kearney, T. AU - Higgins, S. A. AU - Weidhaas, J. PY - 2006 DA - 2006// TI - Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer JO - J Clin Oncol. VL - 24 UR - https://doi.org/10.1200/JCO.2006.06.5664 DO - 10.1200/JCO.2006.06.5664 ID - Haffty2006 ER - TY - JOUR AU - Liedtke, C. AU - Mazouni, C. AU - Hess, K. R. AU - Andre, F. AU - Tordai, A. AU - Mejia, J. A. PY - 2008 DA - 2008// TI - Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer JO - J Clin Oncol. VL - 26 UR - https://doi.org/10.1200/JCO.2007.14.4147 DO - 10.1200/JCO.2007.14.4147 ID - Liedtke2008 ER - TY - JOUR AU - Caudle, A. S. AU - Yu, T. K. AU - Tucker, S. L. AU - Bedrosian, I. AU - Litton, J. K. AU - Gonzalez-Angulo, A. M. PY - 2012 DA - 2012// TI - Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy JO - Breast Cancer Res. VL - 14 UR - https://doi.org/10.1186/bcr3198 DO - 10.1186/bcr3198 ID - Caudle2012 ER - TY - JOUR AU - Zhang, L. AU - Conejo-Garcia, J. R. AU - Katsaros, D. AU - Gimotty, P. A. AU - Massobrio, M. AU - Regnani, G. PY - 2003 DA - 2003// TI - Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer JO - N Engl J Med. VL - 348 UR - https://doi.org/10.1056/NEJMoa020177 DO - 10.1056/NEJMoa020177 ID - Zhang2003 ER - TY - JOUR AU - Galon, J. AU - Costes, A. AU - Sanchez-Cabo, F. AU - Kirilovsky, A. AU - Mlecnik, B. AU - Lagorce-Pages, C. PY - 2006 DA - 2006// TI - Type, density, and location of immune cells within human colorectal tumors predict clinical outcome JO - Science (New York, NY) VL - 313 UR - https://doi.org/10.1126/science.1129139 DO - 10.1126/science.1129139 ID - Galon2006 ER - TY - JOUR AU - Salgado, R. AU - Denkert, C. AU - Demaria, S. AU - Sirtaine, N. AU - Klauschen, F. AU - Pruneri, G. PY - 2015 DA - 2015// TI - The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 JO - Ann Oncol. VL - 26 UR - https://doi.org/10.1093/annonc/mdu450 DO - 10.1093/annonc/mdu450 ID - Salgado2015 ER - TY - JOUR AU - Ladoire, S. AU - Mignot, G. AU - Dabakuyo, S. AU - Arnould, L. AU - Apetoh, L. AU - Rebe, C. PY - 2011 DA - 2011// TI - In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival JO - J Pathol. VL - 224 UR - https://doi.org/10.1002/path.2866 DO - 10.1002/path.2866 ID - Ladoire2011 ER - TY - JOUR AU - Ibrahim, E. M. AU - Al-Foheidi, M. E. AU - Al-Mansour, M. M. AU - Kazkaz, G. A. PY - 2014 DA - 2014// TI - The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis JO - Breast Cancer Res Treat. VL - 148 UR - https://doi.org/10.1007/s10549-014-3185-2 DO - 10.1007/s10549-014-3185-2 ID - Ibrahim2014 ER - TY - JOUR AU - Adams, S. AU - Gray, R. J. AU - Demaria, S. AU - Goldstein, L. AU - Perez, E. A. AU - Shulman, L. N. PY - 2014 DA - 2014// TI - Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199 JO - J Clin Oncol. VL - 32 UR - https://doi.org/10.1200/JCO.2013.55.0491 DO - 10.1200/JCO.2013.55.0491 ID - Adams2014 ER - TY - JOUR AU - Perez, E. A. AU - Thompson, E. A. AU - Ballman, K. V. AU - Anderson, S. K. AU - Asmann, Y. W. AU - Kalari, K. R. PY - 2015 DA - 2015// TI - Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab Trial JO - J Clin Oncol. VL - 33 UR - https://doi.org/10.1200/JCO.2014.57.6298 DO - 10.1200/JCO.2014.57.6298 ID - Perez2015 ER - TY - JOUR AU - Dieci, M. V. AU - Criscitiello, C. AU - Goubar, A. AU - Viale, G. AU - Conte, P. AU - Guarneri, V. PY - 2014 DA - 2014// TI - Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study JO - Ann Oncol. VL - 25 UR - https://doi.org/10.1093/annonc/mdt556 DO - 10.1093/annonc/mdt556 ID - Dieci2014 ER - TY - JOUR AU - Mahmoud, S. M. AU - Paish, E. C. AU - Powe, D. G. AU - Macmillan, R. D. AU - Grainge, M. J. AU - Lee, A. H. PY - 2011 DA - 2011// TI - Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer JO - J Clin Oncol. VL - 29 UR - https://doi.org/10.1200/JCO.2010.30.5037 DO - 10.1200/JCO.2010.30.5037 ID - Mahmoud2011 ER - TY - JOUR AU - Liu, S. AU - Lachapelle, J. AU - Leung, S. AU - Gao, D. AU - Foulkes, W. D. AU - Nielsen, T. O. PY - 2012 DA - 2012// TI - CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer JO - Breast Cancer Res. VL - 14 UR - https://doi.org/10.1186/bcr3148 DO - 10.1186/bcr3148 ID - Liu2012 ER - TY - JOUR AU - Ali, H. R. AU - Provenzano, E. AU - Dawson, S. J. AU - Blows, F. M. AU - Liu, B. AU - Shah, M. PY - 2014 DA - 2014// TI - Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients JO - Ann Oncol. VL - 25 UR - https://doi.org/10.1093/annonc/mdu191 DO - 10.1093/annonc/mdu191 ID - Ali2014 ER - TY - JOUR AU - Liu, F. AU - Lang, R. AU - Zhao, J. AU - Zhang, X. AU - Pringle, G. A. AU - Fan, Y. PY - 2011 DA - 2011// TI - CD8(+) cytotoxic T cell and FOXP3(+) regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes JO - Breast Cancer Res Treat. VL - 130 UR - https://doi.org/10.1007/s10549-011-1647-3 DO - 10.1007/s10549-011-1647-3 ID - Liu2011 ER - TY - JOUR AU - Liyanage, U. K. AU - Moore, T. T. AU - Joo, H. G. AU - Tanaka, Y. AU - Herrmann, V. AU - Doherty, G. PY - 2002 DA - 2002// TI - Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma JO - J Immunol. VL - 169 UR - https://doi.org/10.4049/jimmunol.169.5.2756 DO - 10.4049/jimmunol.169.5.2756 ID - Liyanage2002 ER - TY - JOUR AU - Viguier, M. AU - Lemaitre, F. AU - Verola, O. AU - Cho, M. S. AU - Gorochov, G. AU - Dubertret, L. PY - 2004 DA - 2004// TI - Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells JO - J Immunol. VL - 173 UR - https://doi.org/10.4049/jimmunol.173.2.1444 DO - 10.4049/jimmunol.173.2.1444 ID - Viguier2004 ER - TY - JOUR AU - Mahmoud, S. M. AU - Paish, E. C. AU - Powe, D. G. AU - Macmillan, R. D. AU - Lee, A. H. AU - Ellis, I. O. PY - 2011 DA - 2011// TI - An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer JO - Breast Cancer Res Treat. VL - 127 UR - https://doi.org/10.1007/s10549-010-0987-8 DO - 10.1007/s10549-010-0987-8 ID - Mahmoud2011 ER - TY - JOUR AU - Oda, N. AU - Shimazu, K. AU - Naoi, Y. AU - Morimoto, K. AU - Shimomura, A. AU - Shimoda, M. PY - 2012 DA - 2012// TI - Intratumoral regulatory T cells as an independent predictive factor for pathological complete response to neoadjuvant paclitaxel followed by 5-FU/epirubicin/cyclophosphamide in breast cancer patients JO - Breast Cancer Res Treat. VL - 136 UR - https://doi.org/10.1007/s10549-012-2245-8 DO - 10.1007/s10549-012-2245-8 ID - Oda2012 ER - TY - JOUR AU - West, N. R. AU - Kost, S. E. AU - Martin, S. D. AU - Milne, K. AU - Deleeuw, R. J. AU - Nelson, B. H. PY - 2013 DA - 2013// TI - Tumour-infiltrating FOXP3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer JO - Br J Cancer. VL - 108 UR - https://doi.org/10.1038/bjc.2012.524 DO - 10.1038/bjc.2012.524 ID - West2013 ER - TY - JOUR AU - Apetoh, L. AU - Ghiringhelli, F. AU - Tesniere, A. AU - Obeid, M. AU - Ortiz, C. AU - Criollo, A. PY - 2007 DA - 2007// TI - Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy JO - Nat Med. VL - 13 UR - https://doi.org/10.1038/nm1622 DO - 10.1038/nm1622 ID - Apetoh2007 ER - TY - JOUR AU - Andre, F. AU - Dieci, M. V. AU - Dubsky, P. AU - Sotiriou, C. AU - Curigliano, G. AU - Denkert, C. PY - 2013 DA - 2013// TI - Molecular pathways: involvement of immune pathways in the therapeutic response and outcome in breast cancer JO - Clin Cancer Res. VL - 19 UR - https://doi.org/10.1158/1078-0432.CCR-11-2701 DO - 10.1158/1078-0432.CCR-11-2701 ID - Andre2013 ER - TY - JOUR AU - Demaria, S. AU - Volm, M. D. AU - Shapiro, R. L. AU - Yee, H. T. AU - Oratz, R. AU - Formenti, S. C. PY - 2001 DA - 2001// TI - Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy JO - Clin Cancer Res. VL - 7 ID - Demaria2001 ER - TY - JOUR AU - Ladoire, S. AU - Arnould, L. AU - Apetoh, L. AU - Coudert, B. AU - Martin, F. AU - Chauffert, B. PY - 2008 DA - 2008// TI - Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3+ regulatory T cells JO - Clin Cancer Res. VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-07-4491 DO - 10.1158/1078-0432.CCR-07-4491 ID - Ladoire2008 ER - TY - JOUR AU - Fu, J. AU - Xu, D. AU - Liu, Z. AU - Shi, M. AU - Zhao, P. AU - Fu, B. PY - 2007 DA - 2007// TI - Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients JO - Gastroenterology. VL - 132 UR - https://doi.org/10.1053/j.gastro.2007.03.102 DO - 10.1053/j.gastro.2007.03.102 ID - Fu2007 ER - TY - JOUR AU - Wolff, A. C. AU - Hammond, M. E. AU - Schwartz, J. N. AU - Hagerty, K. L. AU - Allred, D. C. AU - Cote, R. J. PY - 2007 DA - 2007// TI - American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer JO - J Clin Oncol. VL - 25 UR - https://doi.org/10.1200/JCO.2006.09.2775 DO - 10.1200/JCO.2006.09.2775 ID - Wolff2007 ER - TY - JOUR AU - Urruticoechea, A. AU - Smith, I. E. AU - Dowsett, M. PY - 2005 DA - 2005// TI - Proliferation marker Ki-67 in early breast cancer JO - J Clin Oncol. VL - 23 UR - https://doi.org/10.1200/JCO.2005.07.501 DO - 10.1200/JCO.2005.07.501 ID - Urruticoechea2005 ER - TY - JOUR AU - Azambuja, E. AU - Cardoso, F. AU - Castro, J. G. AU - Colozza, M. AU - Mano, M. S. AU - Durbecq, V. PY - 2007 DA - 2007// TI - Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients JO - Br J Cancer. VL - 96 UR - https://doi.org/10.1038/sj.bjc.6603756 DO - 10.1038/sj.bjc.6603756 ID - Azambuja2007 ER - TY - JOUR AU - Lerma, E. AU - Peiro, G. AU - Ramon, T. AU - Fernandez, S. AU - Martinez, D. AU - Pons, C. PY - 2007 DA - 2007// TI - Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas) JO - Mod Pathol. VL - 20 UR - https://doi.org/10.1038/modpathol.3800961 DO - 10.1038/modpathol.3800961 ID - Lerma2007 ER - TY - JOUR AU - Rakha, E. A. AU - Reis-Filho, J. S. AU - Ellis, I. O. PY - 2008 DA - 2008// TI - Basal-like breast cancer: a critical review JO - J Clin Oncol. VL - 26 UR - https://doi.org/10.1200/JCO.2007.13.1748 DO - 10.1200/JCO.2007.13.1748 ID - Rakha2008 ER - TY - JOUR AU - Symmans, W. F. AU - Peintinger, F. AU - Hatzis, C. AU - Rajan, R. AU - Kuerer, H. AU - Valero, V. PY - 2007 DA - 2007// TI - Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy JO - J Clin Oncol. VL - 25 UR - https://doi.org/10.1200/JCO.2007.10.6823 DO - 10.1200/JCO.2007.10.6823 ID - Symmans2007 ER - TY - JOUR AU - Berke, G. PY - 1994 DA - 1994// TI - The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects JO - Annu Rev Immunol. VL - 12 UR - https://doi.org/10.1146/annurev.iy.12.040194.003511 DO - 10.1146/annurev.iy.12.040194.003511 ID - Berke1994 ER - TY - JOUR AU - Segal, N. H. AU - Parsons, D. W. AU - Peggs, K. S. AU - Velculescu, V. AU - Kinzler, K. W. AU - Vogelstein, B. PY - 2008 DA - 2008// TI - Epitope landscape in breast and colorectal cancer JO - Cancer Res. VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-3095 DO - 10.1158/0008-5472.CAN-07-3095 ID - Segal2008 ER - TY - JOUR AU - Zitvogel, L. AU - Kepp, O. AU - Kroemer, G. PY - 2011 DA - 2011// TI - Immune parameters affecting the efficacy of chemotherapeutic regimens JO - Nat Rev Clin Oncol. VL - 8 UR - https://doi.org/10.1038/nrclinonc.2010.223 DO - 10.1038/nrclinonc.2010.223 ID - Zitvogel2011 ER - TY - JOUR AU - Muenst, S. AU - Soysal, S. D. AU - Gao, F. AU - Obermann, E. C. AU - Oertli, D. AU - Gillanders, W. E. PY - 2013 DA - 2013// TI - The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer JO - Breast Cancer Res Treat. VL - 139 UR - https://doi.org/10.1007/s10549-013-2581-3 DO - 10.1007/s10549-013-2581-3 ID - Muenst2013 ER - TY - JOUR AU - Muenst, S. AU - Schaerli, A. R. AU - Gao, F. AU - Daster, S. AU - Trella, E. AU - Droeser, R. A. PY - 2014 DA - 2014// TI - Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer JO - Breast Cancer Res Treat. VL - 146 UR - https://doi.org/10.1007/s10549-014-2988-5 DO - 10.1007/s10549-014-2988-5 ID - Muenst2014 ER - TY - JOUR AU - Walunas, T. L. AU - Lenschow, D. J. AU - Bakker, C. Y. AU - Linsley, P. S. AU - Freeman, G. J. AU - Green, J. M. PY - 1994 DA - 1994// TI - CTLA-4 can function as a negative regulator of T cell activation JO - Immunity. VL - 1 UR - https://doi.org/10.1016/1074-7613(94)90071-X DO - 10.1016/1074-7613(94)90071-X ID - Walunas1994 ER - TY - JOUR AU - Watanabe, N. AU - Gavrieli, M. AU - Sedy, J. R. AU - Yang, J. AU - Fallarino, F. AU - Loftin, S. K. PY - 2003 DA - 2003// TI - BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1 JO - Nat Immunol. VL - 4 UR - https://doi.org/10.1038/ni944 DO - 10.1038/ni944 ID - Watanabe2003 ER - TY - JOUR AU - Brahmer, J. R. AU - Tykodi, S. S. AU - Chow, L. Q. AU - Hwu, W. J. AU - Topalian, S. L. AU - Hwu, P. PY - 2012 DA - 2012// TI - Safety and activity of anti-PD-L1 antibody in patients with advanced cancer JO - N Engl J Med. VL - 366 UR - https://doi.org/10.1056/NEJMoa1200694 DO - 10.1056/NEJMoa1200694 ID - Brahmer2012 ER - TY - JOUR AU - Topalian, S. L. AU - Hodi, F. S. AU - Brahmer, J. R. AU - Gettinger, S. N. AU - Smith, D. C. AU - McDermott, D. F. PY - 2012 DA - 2012// TI - Safety, activity, and immune correlates of anti-PD-1 antibody in cancer JO - N Engl J Med. VL - 366 UR - https://doi.org/10.1056/NEJMoa1200690 DO - 10.1056/NEJMoa1200690 ID - Topalian2012 ER - TY - JOUR AU - Hamid, O. AU - Robert, C. AU - Daud, A. AU - Hodi, F. S. AU - Hwu, W. J. AU - Kefford, R. PY - 2013 DA - 2013// TI - Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma JO - N Engl J Med. VL - 369 UR - https://doi.org/10.1056/NEJMoa1305133 DO - 10.1056/NEJMoa1305133 ID - Hamid2013 ER -